An analysis of surgical complications, morbidity, and cost calculation in patients undergoing multimodal treatment for operable oropharyngeal carcinoma

Laryngoscope

Volumn 117, Issue 1, 2007, Pages 101-105

  Preuss, Simon F ^a   Quante, Gero ^a   Semrau, Robert ^a   Mueller, Rolf Peter ^a   Klussmann, Jens Peter ^a   Guntinas Lichius, Orlando ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Complications; Cost calculation; Morbidity; Multimodal therapy; Oropharyngeal carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER RADIOTHERAPY; CANCER SURGERY; COST OF ILLNESS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OROPHARYNX CANCER; OROPHARYNX CARCINOMA; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRACHEOSTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DIRECT SERVICE COSTS; FEMALE; GASTROSTOMY; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; OROPHARYNGEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TRACHEOSTOMY; TREATMENT OUTCOME;

EID: 33846069682     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000246191.90021.5e     Document Type: Article

References (15)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Nasri S, Oh Y, Calcaterra TC. Transpharyngeal approach to base of tongue tumors: a comparative study. Laryngoscope 1996;106:945-950.
3. Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
4. Sessions DG, Lenox J, Spector GJ, Chao C, Chaudry OA. Analysis of treatment results for base of tongue cancer. Laryngoscope 2003;113:1252-1261.
5. Scholkopf M. The hospital sector in Germany: an overview. World Hosp Health Serv 2000;36:13-18, 36-37.
6. Schmidt K. EBM plus: KBV announces further changes. MMW Fortschr Med 2005;147:44-45.
7. Preuss SF, Dinh V, Klussmann JP, Semrau R, Mueller RP, Guntinas-Lichius O. Outcome of multimodal treatment for oropharyngeal cancer: a 12-year single institution experience. Oral Oncol. In press.
8. Spring PM, Valentino J, Arnold SM, et al. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Cancer 2005;104:1765-1771.
9. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002;94:2967-2980.
10. Cooper JS, Pajak TF, Forastiere AA, et al., for the Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head neck. N Engl J Med 2004;350:1937-1944.
11. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-816.
12. Sabri A. Oropharyngeal reconstruction: current state of the art. Curr Opin Otolaryngol Head Neck Surg 2003;11:251-254.
13. Tschudi D, Stoeckli S, Schmid S. Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope 2003;113:1949-1954.
14. Pourel N, Peiffert D, Lartigau E, Desandes E, Luporsi E, Conroy T. Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys 2002;54:742-751.
15. Nijdam W, Levendag P, Noever I, Groot CU, Agthoven M. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Radiother Oncol 2005;77:65-72.